Titan Biotech Ltd

Titan Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Titan Biotech Ltd

₹ 1,098 -2.00%
29 Oct - close price
titanbiotechltd.com BSE: 524717
About

Incorporated in 1992, Titan Biotech
Ltd manufacturer and exporter of
the Biological products[1]

Key Points

Business Overview:[1]
TBL is an ISO 9001:2008 Certified & cGMP facilitated manufacturer & exporter of biological products used in the fields of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal
Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media,
etc.

Website BSE
  • Market Cap ₹ 907 Cr.
  • Current Price ₹ 1,098
  • High / Low ₹ 1,419 / 374
  • Stock P/E 48.4
  • Book Value ₹ 176
  • Dividend Yield 0.18 %
  • ROCE 17.7 %
  • ROE 13.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
35.00 41.83 30.33 36.84 34.75 43.43 45.98 39.92 43.11 39.89 38.28 35.17 46.50
26.93 31.35 26.19 30.00 26.86 34.71 35.38 32.85 34.86 32.13 33.43 30.60 37.76
Operating Profit 8.07 10.48 4.14 6.84 7.89 8.72 10.60 7.07 8.25 7.76 4.85 4.57 8.74
OPM % 23.06% 25.05% 13.65% 18.57% 22.71% 20.08% 23.05% 17.71% 19.14% 19.45% 12.67% 12.99% 18.80%
0.32 0.86 0.28 0.49 0.28 0.55 0.44 0.48 0.62 0.32 1.59 1.38 0.72
Interest 0.18 0.17 0.14 0.26 0.29 0.28 0.26 0.34 0.31 0.27 0.15 0.08 0.20
Depreciation 0.60 0.64 0.65 0.71 0.80 0.86 0.83 0.84 1.05 1.10 1.18 0.84 1.15
Profit before tax 7.61 10.53 3.63 6.36 7.08 8.13 9.95 6.37 7.51 6.71 5.11 5.03 8.11
Tax % 24.05% 24.98% 25.62% 26.89% 23.73% 25.71% 25.63% 24.02% 24.23% 25.48% 25.64% 25.25% 24.04%
5.78 7.90 2.70 4.64 5.41 6.03 7.38 4.84 5.70 5.00 3.80 3.77 6.16
EPS in Rs 6.99 9.56 3.27 5.61 6.55 7.30 8.93 5.86 6.90 6.05 4.60 4.56 7.45
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
39 40 46 52 56 58 69 122 124 144 164 156 160
36 36 42 47 49 51 59 81 92 114 130 131 134
Operating Profit 3 4 4 6 7 8 11 42 31 30 34 25 26
OPM % 8% 10% 9% 10% 12% 13% 16% 34% 25% 21% 21% 16% 16%
0 0 0 0 0 1 1 0 1 2 2 4 4
Interest 0 1 1 1 2 2 2 1 1 1 1 1 1
Depreciation 1 1 1 1 1 2 2 2 2 3 3 4 4
Profit before tax 2 2 3 3 4 4 8 39 29 28 32 24 25
Tax % 33% 33% 33% 33% 36% 29% 25% 26% 25% 25% 25% 25%
1 2 2 2 2 3 6 29 22 21 24 18 19
EPS in Rs 2.12 2.11 2.22 3.02 3.10 3.73 7.50 34.81 26.24 25.44 28.63 22.11 22.66
Dividend Payout % 35% 36% 34% 25% 24% 0% 13% 4% 6% 7% 7% 9%
Compounded Sales Growth
10 Years: 15%
5 Years: 18%
3 Years: 8%
TTM: -7%
Compounded Profit Growth
10 Years: 27%
5 Years: 26%
3 Years: -6%
TTM: -22%
Stock Price CAGR
10 Years: 43%
5 Years: 54%
3 Years: 60%
1 Year: 25%
Return on Equity
10 Years: 21%
5 Years: 24%
3 Years: 18%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 7 8 8 8 8 8 8 8 8 8 8 8
Reserves 8 13 14 15 17 23 30 58 78 98 120 137
7 8 11 22 25 22 18 10 9 9 8 3
6 5 6 5 5 6 10 10 13 16 15 19
Total Liabilities 28 34 39 50 55 60 65 86 108 131 152 166
11 11 10 11 11 26 25 27 35 36 52 57
CWIP 0 1 5 9 13 0 0 0 4 13 3 2
Investments 0 0 1 1 1 1 1 1 4 12 23 24
17 21 23 29 29 33 39 58 65 70 74 83
Total Assets 28 34 39 50 55 60 65 86 108 131 152 166

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -2 5 -0 2 6 7 18 22 21 21 20
-2 -3 -5 -7 -5 -4 -1 -4 -16 -21 -20 -10
2 3 2 8 0 -2 -6 -10 -4 -2 -3 -8
Net Cash Flow -0 -2 2 2 -3 1 0 4 2 -2 -2 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 52 58 46 44 53 49 55 48 48 53 42 44
Inventory Days 97 134 118 155 202 238 244 177 206 179 208 242
Days Payable 21 17 18 13 12 25 36 18 25 27 15 25
Cash Conversion Cycle 128 175 145 186 243 262 263 207 230 205 234 261
Working Capital Days 58 94 58 86 111 101 105 89 118 109 111 130
ROCE % 14% 14% 12% 13% 13% 13% 18% 61% 35% 28% 26% 18%

Shareholding Pattern

Numbers in percentages

6 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.78%
0.00% 0.00% 0.00% 0.00% 0.00% 0.23% 0.00% 0.00% 0.00% 0.01% 0.03% 0.03%
44.11% 44.12% 44.13% 44.13% 44.12% 43.90% 44.12% 44.13% 44.12% 44.11% 44.10% 44.19%
No. of Shareholders 18,86618,75218,10617,45515,75615,87615,85015,70016,03816,37016,32816,040

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports